COMMUNIQUÉS West-GlobeNewswire

Forward Pharma Announces Completion of Corporate Restructuring Plan
22/11/2017
COPENHAGEN, Denmark, Nov. 22, 2017 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ: FWP ) (“Forward Pharma”) today announced the completion of its previously announced corporate restructuring plan (the “Restructuring”) [...]
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
22/11/2017
BRIDGEWATER, N.J., Nov. 22, 2017 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq: INSM ), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today announced the granting of [...]
RedHawk Announces First Quarter Results
22/11/2017
LAFAYETTE, La., Nov. 22, 2017 (GLOBE NEWSWIRE) -- RedHawk Holdings Corp. (OTCQB:IDNG) (“RedHawk” or the “Company”) announced today its results for the three-month period ended September 30, 2017 as it continues to [...]
Cannevert Scientists to Present Their First Peer-Reviewed Research at December’s Prestigious British Pharmacological Society Meeting in London, UK
22/11/2017
VANCOUVER, British Columbia, Nov. 22, 2017 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt: 2VP ), (“Veritas” or the “Company”) announces that the scientists of its research arm, Cannevert [...]
TESARO Announces Participation in Two Investor Conferences
22/11/2017
WALTHAM, Mass., Nov. 22, 2017 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ: TSRO ), an oncology-focused biopharmaceutical company, today announced its participation in two upcoming investor conferences. The two conferences [...]
Prothena to Participate in the Evercore ISI Biopharma Catalyst/Deep Dive Conference
22/11/2017
DUBLIN, Ireland, Nov. 22, 2017 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ: PRTA ), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel therapies in [...]
Adamas to Present at Two Upcoming Investor Conferences
22/11/2017
EMERYVILLE, Calif., Nov. 22, 2017 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS ) today announced that company management is scheduled to present at two upcoming investor conferences: Richard A. King, [...]
GENFIT: Positive Outcome from the 18-month Pre-Planned Safety Review by the DSMB, in RESOLVE-IT Phase 3 Clinical Trial with elafibranor
22/11/2017
GENFIT: Positive Outcome from the 18-month Pre-Planned Safety Review by the DSMB, in RESOLVE-IT Phase 3 Clinical Trial with elafibranor Safety data, including adverse events and laboratory data, were reviewed by the [...]
GENFIT : issue positive du DSMB suite à la revue planifiée à 18 mois des données de tolérance et de sécurité d'emploi d'elafibranor, dans l'étude clinique de Phase 3 RESOLVE-IT
22/11/2017
GENFIT : issue positive du DSMB suite à la revue planifiée à 18 mois des données de tolérance et de sécurité d'emploi d'elafibranor, dans l'étude clinique de Phase 3 RESOLVE-IT Les données de tolérance et de sécurité d' [...]
Innate Pharma provides an update on Lirilumab
22/11/2017
INNATE PHARMA PROVIDES AN UPDATE ON LIRILUMAB Lirilumab continues to be well-tolerated in monotherapy and in combination across multiple tumor indications in an exploratory clinical program with partner Bristol-Myers [...]
Innate Pharma annonce une mise à jour du programme Lirilumab
22/11/2017
INNATE PHARMA ANNONCE UNE MISE A JOUR DU PROGRAMME LIRILUMAB Dans le programme clinique exploratoire mené par Bristol-Myers Squibb, lirilumab continue d'être bien toléré en monothérapie et en combinaison dans [...]
Sienna Senior Living named one of Canada’s Most Admired Corporate Cultures for 2017
22/11/2017
MARKHAM, Ontario, Nov. 22, 2017 (GLOBE NEWSWIRE) -- Sienna Senior Living (TSX: SIA ) (“ Sienna ”) announced today that it has been named among Canada’s Most Admired Corporate Cultures in the Enterprise category by [...]
Analogic Announces Timing for First Quarter 2018 Earnings Conference Call and Webcast
22/11/2017
PEABODY, Mass., Nov. 22, 2017 (GLOBE NEWSWIRE) -- Analogic Corporation (Nasdaq: ALOG ) announced today that it will conduct a conference call on Wednesday, December 6, 2017, at 5:00 p.m. (ET) to discuss results for the [...]
Axim Biotechnologies Reports Third Quarter 2017 Results
22/11/2017
NEW YORK, Nov. 22, 2017 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced results for the quarter ended September 30, [...]
Dr. Robert M. Taft Installed as President of the American College of Prosthodontists
22/11/2017
Chicago, IL, Nov. 22, 2017 (GLOBE NEWSWIRE) -- Robert M. Taft, DDS, FACP , has been installed as president of the American College of Prosthodontists (ACP) . Dr. Taft was sworn in during the 47 th Annual Session of the [...]
Aquinox to Participate in 29th Annual Piper Jaffray Healthcare Conference
22/11/2017
VANCOUVER, British Columbia, Nov. 22, 2017 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“ Aquinox ”) (NASDAQ: AQXP ), a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in [...]
Van Leeuwenhoeck Institute Updates Immuron Research Coverage
22/11/2017
MELBOURNE, Australia, Nov. 22, 2017 (GLOBE NEWSWIRE) -- Immuron Limited (ASX:IMC) (the “Company”) wishes to advise investors that Van Leeuwenhoeck Institute, a prominent European and US-based Life Sciences Research and [...]
Collegium to Present at the 29th Annual Piper Jaffray Healthcare Conference
22/11/2017
CANTON, Mass., Nov. 22, 2017 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL ) today announced that senior management will participate in a fireside chat at the 29 th Annual Piper Jaffray Healthcare [...]
Teligent, Inc. Announces First FDA Generic Approval of Hydrocortisone Butyrate Lotion 0.1%
22/11/2017
BUENA, N.J., Nov. 22, 2017 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT ), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s abbreviated new drug [...]

Pages